Skip to main content
. 2023 Feb 13;15(4):930. doi: 10.3390/nu15040930

Figure 2.

Figure 2

Sodium butyrate (NaB) increases dopamine (DA) and serotonin (5-HT) levels in the striatum of mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson’s disease (PD). Levels of the neurotransmitters (A) DA, (B) 5-HT, and their metabolites (C) dihydroxyphenylacetic acid (DOPAC), and (D) 5-hydroxyindoleacetic acid (5-HIAA) in the striatum. n = 5 mice per group; * p < 0.05, ** p < 0.01; data are presented as means ± SEM.